ir.archcapgroup.com ir.archcapgroup.com

ir.archcapgroup.com

Arch > Investor Information

Earnings Releases and Supplements. Non-US. Subsidiary Information. 07/30/2015 11:00 AM ET. Q2 2015 Arch Capital Group Earnings Conference Call. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Arch Capital Group Earnings Conference Call. Thursday, July 30, 2015. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. Maintain a disciplined underwriting approach to enable us to se...

http://ir.archcapgroup.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.ARCHCAPGROUP.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

March

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 6 reviews
5 star
0
4 star
6
3 star
0
2 star
0
1 star
0

Hey there! Start your review of ir.archcapgroup.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.9 seconds

CONTACTS AT IR.ARCHCAPGROUP.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Arch > Investor Information | ir.archcapgroup.com Reviews
<META>
DESCRIPTION
Earnings Releases and Supplements. Non-US. Subsidiary Information. 07/30/2015 11:00 AM ET. Q2 2015 Arch Capital Group Earnings Conference Call. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Arch Capital Group Earnings Conference Call. Thursday, July 30, 2015. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. Maintain a disciplined underwriting approach to enable us to se...
<META>
KEYWORDS
1 about arch
2 insurance
3 reinsurance
4 mortgage
5 investors
6 visit arch corporate
7 affiliates
8 roamright com
9 gulfre com
10 watfordre com
CONTENT
Page content here
KEYWORDS ON
PAGE
about arch,insurance,reinsurance,mortgage,investors,visit arch corporate,affiliates,roamright com,gulfre com,watfordre com,media center,careers,staff finder,global office finder,office directory,investor information,stock information,stock quote,webcasts
SERVER
Microsoft-IIS/8.5
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Arch > Investor Information | ir.archcapgroup.com Reviews

https://ir.archcapgroup.com

Earnings Releases and Supplements. Non-US. Subsidiary Information. 07/30/2015 11:00 AM ET. Q2 2015 Arch Capital Group Earnings Conference Call. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Arch Capital Group Earnings Conference Call. Thursday, July 30, 2015. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. Maintain a disciplined underwriting approach to enable us to se...

INTERNAL PAGES

ir.archcapgroup.com ir.archcapgroup.com
1

IRWeblink

http://ir.archcapgroup.com/GenPage.aspx?IID=103577&amp;GKP=210207

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

2

Arch > Stock Information >Historical Prices

http://ir.archcapgroup.com/HistoricPrices.aspx?iid=103577

Earnings Releases and Supplements. Non-US. Subsidiary Information. S&P Global Market Intelligence. Arch Capital Group Ltd. to Report 2014 First Quarter Results on May 1, 2014. More News and Events. View our Financial Reports filed with the SEC here.

3

Arch > Financial Reports >Annual Reports

http://ir.archcapgroup.com/FinancialDocs.aspx?iid=103577

Earnings Releases and Supplements. Non-US. Subsidiary Information. Click the link to the right to download :. Arch Capital Group Ltd. to Report 2014 First Quarter Results on May 1, 2014. More News and Events. View our Financial Reports filed with the SEC here.

4

IRWeblink

http://ir.archcapgroup.com/file.aspx?IID=103577&amp;FID=29205637

Thank you for your interest in IR Solutions. You have reached this page because the URL you have requested is no longer available, or you do not have permission to view it. For more information on the most comprehensive IR web site management tool available, please click here. If you have any questions, e-mail IRSupport@snl.com. Or call (866) 802-9128 and ask for an IR Solutions sales representative. To return to the main SNL Financial homepage.

5

Arch > Investor Information

http://ir.archcapgroup.com/CorporateProfile.aspx?iid=103577

Earnings Releases and Supplements. Non-US. Subsidiary Information. 8/16/2016 08:30 AM ET. Arch Capital Group Corporate Conference Call. As of August 19, 2016 -. Minimum 20 minute delay. Arch Capital Group Corporate Conference Call. Arch Capital Group Corporate Conference Call. Tuesday, August 16, 2016. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. View All Press Releases. Arch C...

UPGRADE TO PREMIUM TO VIEW 17 MORE

TOTAL PAGES IN THIS WEBSITE

22

OTHER SITES

ir.aptose.com ir.aptose.com

Aptose Biosciences - Investors - Overview

SELECT SOLID TUMOR INDICATIONS. CDX2 AND KRUPPEL-LIKE FACTOR BIOLOGY. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. January 10, 2017. 160;at 9:00 am PT. Aptose Biosciences, Inc. at 9th Annual Biotech Showcase. Tuesday, January 10, 2017 . 9:00 am PT  . Click here for webcast. Click here to add this event to your calendar. January 5, 2017. Aptose Biosciences to Present at Biotech Showcase 2017 Conference. December 29, 2016. Aptose Biosciences Provides Update on APTO-253 Development.

ir.aqr.com ir.aqr.com

AQR Capital - Investor Relations - Overview

Investor and Media Contact. There are currently no news releases. Primary IR and Media Contact. Quotes delayed at least 15 minutes. Market data provided by Interactive Data. Powered and implemented by Interactive Data Managed Solutions.

ir.aquaamerica.com ir.aquaamerica.com

Investor Relations | Aqua America

Skip to main navigation. Reconciliation of GAAP to Non-GAAP Financial Measures. Regulated segment - Efficiency ratio adjusted for purchased water. Reconciliation of GAAP to Non-GAAP financial measures - EBITDA reconciliation for continuing operations. Adjusted Net Income EPS Q4 2017. Dividend Reinvestment and DSPP. There are currently no events to display. Feb 27, 2018. Aqua America Reports Earnings for 2017, Announces 2018 Guidance. Feb 5, 2018. Aqua America Declares March 2018 Dividend. Feb 1, 2018.

ir.arafaholding.com ir.arafaholding.com

Arafa Holding | Investor Relations

Board and Shareholders Actions. Share and Corporate Information. Luxury, Formal and Casual Wear across own brands. Textiles, Apparel and Tailoring, Retail and Distribution. Concrete, with 47 retail stores nationwide across Egypt. Learn about Arafa Holding's business model, strategy, brands and partnerships through our downloadable presentations in the Presentations and Publications center. As of 16:02, on Thu, Aug, 13 2015. Arafa Earnings Release 1Q2015. Arafa Holding Financials 1Q2015 (Arabic).

ir.arcadis.com ir.arcadis.com

Arcadis Investors - ARCADIS NV - Investor Relations

United Kingdom (ARCADIS AYH). ARCADIS at a Glance. Reasons to invest in ARCADIS. Share Quote and Chart. Risk and Risk Management. IR Team and Subscriptions. To opt-in to receive our quarterly retail investor newsletter. ARCADIS Q2 2015 Results. Jul 29, 2015 at 3:00 PM CET. Tetra Tech, Inc. 07 Aug 2015 latest: 17:35 CET. Euro; 22.38. Amounts in € millions unless otherwise stated. Organic gross revenue growth. Organic net revenue growth. Net income per share (in €). Net income from operations.

ir.archcapgroup.com ir.archcapgroup.com

Arch > Investor Information

Earnings Releases and Supplements. Non-US. Subsidiary Information. 07/30/2015 11:00 AM ET. Q2 2015 Arch Capital Group Earnings Conference Call. As of August 14, 2015 -. Minimum 20 minute delay. Q2 2015 Arch Capital Group Earnings Conference Call. Thursday, July 30, 2015. We seek to increase shareholder value through three main strategic principles:. Selectively pursue diverse specialty markets where we can apply our knowledge and expertise;. Maintain a disciplined underwriting approach to enable us to se...

ir.archtherapeutics.com ir.archtherapeutics.com

Overview :: Arch Therapeutics, Inc. (ARTH)

View our latest Corporate Presentation. Go to Detailed Stock Info ›. Arch Therapeutics Announces Private Placement. Arch Therapeutics Obtains Additional Safety Data for Its AC5 Surgical Hemostatic Device(TM) in Successful Preclinical Toxicity Test. Arch Therapeutics Initiates Research and Development Collaboration With CURAM Centre for Research in Medical Devices. Go to Press Releases ›. Visit our FAQs for commonly asked questions and answers. 1859 Whitney Mesa Dr. Henderson, NV 89014.

ir.arctreit.com ir.arctreit.com

ARCTREIT.COM

ir.ardelyx.com ir.ardelyx.com

Investor Relations - Ardelyx

Non-Systemic Therapies, Reduced Risk. Annual Reports and Proxies. We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Ardelyxs financial performance into perspective. 070 ( 3.84%). 4:00 PM ET on August 14, 2015. Delayed at least 20 minutes. August 12, 2015. Ardelyx Reports Second Quarter 2015 Financial Results. August 5, 2015. Ardelyx to Report Second Quarter 2015 Financial Results on August 12, 2015.

ir.argostherapeutics.com ir.argostherapeutics.com

Investors – Argos Therapeutics

Platform & Pipeline. Platform & Pipeline. Aug 14, 2015 at 4:00 PM ET. Intraday data provided by eSignal. Press Releases View all. Argos Therapeutics Reports Second Quarter 2015 Financial Results and Operational Highlights. Argos Therapeutics Announces Pilot Clinical Trial of AGS-003 as Neoadjuvant Immunotherapy for Localized Renal Cell Carcinoma. Events and Presentations View all. May 14, 2015 at 4:30 PM ET. Argos Therapeutics, Inc. First Quarter 2015 Financial Results Conference Call.

ir.arm.com ir.arm.com

ARM Holdings - Investor Relations - ARM Holdings plc - ARM Holdings plc - Investors

This site uses cookies to store information on your computer. By continuing to use our site, you consent to our cookies. PLEASE NOTE: If you have adjusted your cookie settings on www.arm.com. These settings do not apply to this website. ARM websites use two types of cookie: ( 1). Those that enable the site to function and perform as required; and (2). To learn how they can be disabled. By disabling cookies some features of the site will not work. Accept and hide this message. Mali Cost Efficient Graphics.